CIK 0001356090 · Non-accelerated filer<br>Smaller reporting company
PRECIGEN, INC.
Sign in to watch- Ticker
- PGEN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 301-556-9900
- Business address
- 20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876
- Former names
- INTREXON CORP
- 144 Insider Sale of Securities
- 4 Planned sale Chief Financial Officer sold 100,000 shares at $6.06 ($606,000)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Financial Officer sold 200,000 shares at an average $5.57 ($1,113,143)
- 4 Planned sale Chief Operating Officer sold 42,924 shares at $5.85 ($251,105)
- 4 Planned sale President and CEO sold 346,836 shares at $5.89 ($2,042,864)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Executive or director change · Shareholder vote results
- 4 Open-market sale Chief Financial Officer sold 41,884 shares at $4.36 ($182,614)
- 4 Open-market sale Chief Commercial Officer sold 30,272 shares at $4.36 ($131,986)
- 4 Open-market sale Chief Operating Officer sold 42,703 shares at $4.36 ($186,185)
- 4 Open-market sale Chief Legal Officer sold 29,131 shares at $4.36 ($127,011)
- 4 Open-market sale President and CEO sold 119,250 shares at $4.36 ($519,930)
- 4 Option exercise Chief Financial Officer acquired 87,500 shares (option exercise)
- 4 Option exercise Chief Commercial Officer acquired 62,500 shares (option exercise)
- 4 Option exercise Chief Operating Officer acquired 90,000 shares (option exercise)
- 4 Option exercise President and CEO acquired 250,000 shares (option exercise)
Page 2 of 67 · 1,325 filings